223 related articles for article (PubMed ID: 32886187)
1. Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Hölzl-Armstrong L; Kucab JE; Moody S; Zwart EP; Loutkotová L; Duffy V; Luijten M; Gamboa da Costa G; Stratton MR; Phillips DH; Arlt VM
Arch Toxicol; 2020 Dec; 94(12):4173-4196. PubMed ID: 32886187
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Hölzl-Armstrong L; Moody S; Kucab JE; Zwart EP; Bellamri M; Luijten M; Turesky RJ; Stratton MR; Arlt VM; Phillips DH
Food Chem Toxicol; 2021 Jan; 147():111855. PubMed ID: 33189884
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of acrylamide and glycidamide.
Besaratinia A; Pfeifer GP
J Natl Cancer Inst; 2004 Jul; 96(13):1023-9. PubMed ID: 15240786
[TBL] [Abstract][Full Text] [Related]
5. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.
Kucab JE; Zwart EP; van Steeg H; Luijten M; Schmeiser HH; Phillips DH; Arlt VM
DNA Repair (Amst); 2016 Mar; 39():21-33. PubMed ID: 26723900
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of N-hydroxy-4-aminobiphenyl in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Hölzl-Armstrong L; Kucab JE; Zwart EP; Luijten M; Phillips DH; Arlt VM
Environ Mol Mutagen; 2021 Apr; 62(4):252-264. PubMed ID: 33620775
[TBL] [Abstract][Full Text] [Related]
7. Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene
Hölzl-Armstrong L; Kucab JE; Korenjak M; Luijten M; Phillips DH; Zavadil J; Arlt VM
Methods Protoc; 2019 Nov; 2(4):. PubMed ID: 31766274
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of diesel exhaust carcinogens in primary and immortalized human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Kucab JE; Phillips DH; Arlt VM
Environ Mol Mutagen; 2012 Apr; 53(3):207-17. PubMed ID: 22351035
[TBL] [Abstract][Full Text] [Related]
9. Acrylamide-induced carcinogenicity in mouse lung involves mutagenicity: cII gene mutations in the lung of big blue mice exposed to acrylamide and glycidamide for up to 4 weeks.
Manjanatha MG; Guo LW; Shelton SD; Doerge DR
Environ Mol Mutagen; 2015 Jun; 56(5):446-56. PubMed ID: 25639614
[TBL] [Abstract][Full Text] [Related]
10. Nutlin-3a selects for cells harbouring TP53 mutations.
Kucab JE; Hollstein M; Arlt VM; Phillips DH
Int J Cancer; 2017 Feb; 140(4):877-887. PubMed ID: 27813088
[TBL] [Abstract][Full Text] [Related]
11. Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.
Kucab JE; Phillips DH; Arlt VM
FEBS J; 2010 Jun; 277(12):2567-83. PubMed ID: 20553493
[TBL] [Abstract][Full Text] [Related]
12. The carcinogenic air pollutant 3-nitrobenzanthrone induces GC to TA transversion mutations in human p53 sequences.
vom Brocke J; Krais A; Whibley C; Hollstein MC; Schmeiser HH
Mutagenesis; 2009 Jan; 24(1):17-23. PubMed ID: 18765419
[TBL] [Abstract][Full Text] [Related]
13. Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells.
Mei N; Hu J; Churchwell MI; Guo L; Moore MM; Doerge DR; Chen T
Food Chem Toxicol; 2008 Feb; 46(2):628-36. PubMed ID: 18029077
[TBL] [Abstract][Full Text] [Related]
14. Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans.
Zhivagui M; Ng AWT; Ardin M; Churchwell MI; Pandey M; Renard C; Villar S; Cahais V; Robitaille A; Bouaoun L; Heguy A; Guyton KZ; Stampfer MR; McKay J; Hollstein M; Olivier M; Rozen SG; Beland FA; Korenjak M; Zavadil J
Genome Res; 2019 Apr; 29(4):521-531. PubMed ID: 30846532
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts.
Martins C; Oliveira NG; Pingarilho M; Gamboa da Costa G; Martins V; Marques MM; Beland FA; Churchwell MI; Doerge DR; Rueff J; Gaspar JF
Toxicol Sci; 2007 Feb; 95(2):383-90. PubMed ID: 17088317
[TBL] [Abstract][Full Text] [Related]
16. Transmitted mutational events induced in mouse germ cells following acrylamide or glycidamide exposure.
Favor J; Shelby MD
Mutat Res; 2005 Feb; 580(1-2):21-30. PubMed ID: 15668104
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cII gene mutation in the brains of Big Blue mice exposed to acrylamide and glycidamide in drinking water.
Li HF; Shelton SD; Townsend TA; Mei N; Manjanatha MG
J Toxicol Sci; 2016; 41(6):719-730. PubMed ID: 27853100
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide.
Von Tungeln LS; Churchwell MI; Doerge DR; Shaddock JG; McGarrity LJ; Heflich RH; Gamboa da Costa G; Marques MM; Beland FA
Int J Cancer; 2009 May; 124(9):2006-15. PubMed ID: 19123476
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay.
Von Tungeln LS; Doerge DR; Gamboa da Costa G; Matilde Marques M; Witt WM; Koturbash I; Pogribny IP; Beland FA
Int J Cancer; 2012 Nov; 131(9):2008-15. PubMed ID: 22336951
[TBL] [Abstract][Full Text] [Related]
20. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect.
Ghanayem BI; Witt KL; Kissling GE; Tice RR; Recio L
Mutat Res; 2005 Oct; 578(1-2):284-97. PubMed ID: 15982677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
